Fahey, C. C., Clark-Garvey, S., Porten, S., Kamat, A. M., Flaig, T. W., Taylor, J. A., . . . Milowsky, M. I. (2025). Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium. Current Oncology, 32(5), 278. https://doi.org/10.3390/curroncol32050278
Chicago Style (17th ed.) CitationFahey, Catherine C., Sean Clark-Garvey, Sima Porten, Ashish M. Kamat, Thomas W. Flaig, John A. Taylor, William Y. Kim, and Matthew I. Milowsky. "Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium." Current Oncology 32, no. 5 (2025): 278. https://doi.org/10.3390/curroncol32050278.
MLA (9th ed.) CitationFahey, Catherine C., et al. "Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium." Current Oncology, vol. 32, no. 5, 2025, p. 278, https://doi.org/10.3390/curroncol32050278.
